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1. Introduction 
The increasing consumer awareness that diet and health are linked is stimulating innovative 
development of novel products by the food industry. Lactic acid bacteria (LAB) have 
received much attention over recent decades due to the health-promoting properties of 
certain strains, called probiotics. The concept probiotics has been redefined over time. Fuller 
defined it as “A live microbial feed which beneficially affects the host animal by improving 
intestinal microbial balance” (Fuller, 1989). The probiotic products traditionally incorporate 
intestinal species of Lactobacillus because of their long history of safe use in the dairy 
industry and their natural presence in the human intestinal tract, which is known to contain 
a myriad of microbes, collectively called the microbiota. Intestinal LAB in humans are 
intimately associated with the host’s health because they are an important biodefense factor 
in preventing colonization and subsequent proliferation of pathogenic bacteria in the 
intestine. In fact, probiotics have been used for as long as people have eaten fermented 
foods. However, it was Metchnikoff at the turn of the 20th century who first suggested that 
ingested bacteria could have a positive influence on the normal microbial flora of the 
intestinal tract (Metchnikoff, 1907). He hypothesized that lactobacilli were important for 
human health, longevity, and promoted yogurt and other fermented foods as healthy. Food 
derived from plants, animals, or their products often contain many types of microbes. These 
microbes from natural and external sources colonize food by contact, which can occur 
anytime between production and consumption. Microbial contamination of food (i.e. the 
colonization by unwanted microorganisms) can have many undesirable consequences 
ranging from spoilage to food borne illness. However, some microbes possess properties 
that are beneficial for food production or conversion or storage. These food grade 
microorganisms are used to produce a variety of fermented foods (with improved storage 
capability) from raw animal and plant material. Having natural preservatives in mind, LAB 
and their metabolites are good alternatives. The increasing consumer awareness of the risks 
derived not only from food-borne pathogens, but also from the artificial chemical 
preservatives used to control them (Abee et al., 1995), has led to renewed interest in so-called 
“green technologies” including novel approaches for a minimal processing and exploitation 
of bacteriocins for biopreservation (Papagianni, 2003). Biopreservation can be explained as 
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the link between fermentation and preservation, and refers to extension of the shelf-life and 
improvement of the safety of food using microorganisms and/or their metabolites (Kao & 
Frazier, 1966; Klaenhammer, 1988; Holzapfel et al., 1995). Furthermore, the use of LAB and 
or their metabolites for food preservation is generally accepted by consumers as something 
“natural” and “health-promoting” (Montville & Winkowski, 1997). Among LAB, addition of 
Lactobacillus culture to food is an approach to food preservation, it also contributes to taste, 
texture and also inhibits food spoilage bacteria by producing growth inhibiting substances 
like bacteriocins, lactic acid etc. Strategies utilized to study incorporation of biopreservatives 
into food include: direct use of LAB-strains with proven antimicrobial activity as starter 
cultures or food additives, use of biopreservatives preparation in the form of previously 
fermented product, or use of partially-purified, purified or chemically synthesized 
bacteriocins (De Vuyst & Vandamme, 1994).  
2. Food-associated Lactic acid bacteria 
The first essential step in food fermentation is the catabolism of carbohydrates by the LAB. 
LAB as a group exhibit an enormous capacity to degrade different carbohydrates and 
related compounds. LAB are Gram-positive, non-spore forming cocci, coccobacilli or rods 
and most genera have a DNA base composition of less than 50% G+C, lack catalase, grow 
under microaerophilic or anaerobic conditions, and typically ferment glucose mainly to 
lactic acid (homo-fermentative), but can also have lactic acid, CO2, and ethanol/acetic acid 
as end products (hetero-fermentative). In nature, species of the LAB are found in gastro-
intestinal tract (GIT) of mammals and also in fermented food products (dairy, meat, 
vegetables, fruits and beverages). LAB associated with foods are generally restricted to the 
genera Lactobacillus, Lactococcus, Leuconostoc, Pediococcus and Streptococcus. Orla-Jensen (1919) 
proposed a classification of lactic acid bacteria, which was based on morphology, 
temperature range of growth, nutritional characteristics, carbon sources utilization and 
agglutination effects. Orla-Jensen (1919) differentiated three major groups. The first group 
contained Thermobacterium, Streptobacterium and Streptococcus which were all catalase 
negative and produce mainly lactic acid besides traces of other by-products. The second 
group contained Betabacterium and Betacoccus, which also lack catalase but as a rule formed 
detectable amounts of gas and other by-products, besides lactic acid. The third group 
consisting of Microbacterium and Tetracoccus show a positive catalase reaction. In 1960, Van 
den Hammer showed that representative of Betabacterium did not possess fructose-1,6-
bisphosphate aldolase, in contrast to Thermobacterium and Streptobacterium. These findings 
supported the discrimination of the three physiological groups: (i) the obligately  
homo-fermentative lactobacilli, lacking both glucose-6-phosphate dehydrogenase and 6-
phosphogluconate dehydrogenase (Thermobacterium), (ii) the facultatively homo-fermentative 
lactobacilli having both dehydrogenases but degrading glucose preferably via the Embden-
Meyerhof-Parnas pathway (Streptobacterium) and (iii) the obligately hetero-fermentative 
lactobacilli lacking fructose 1,6-bisphosphatealdolase (Betabacterium). Thermobacterium, 
Streptobacterium and Betabacterium were considered to be the three subgenera within the 
genus Lactobacillus.  
The genus Lactobacillus belongs to the large group of lactic acid bacteria. The genus 
Lactobacillus belongs phylogenetically to the phylum Firmicutes (Garrity et al., 2004). The 
family Lactobacillaceae comprises the main family in the order Lactobacillales which itself 
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belongs to the class Bacilli. Lactobacilli can be found in a variety of ecological niches, such as 
plants (fruits, vegetables, cereal grains) or plant-derived materials, silage, fermented foods 
(yogurt, cheese, olives, pickles, salami, etc.), as well as in the oral cavities, GIT, and vaginas 
of human and animals. The bacteria that occupy a niche in the GIT are true residents or 
autochthonous (i.e., found where they are formed). Other bacteria are just “get a lift” 
through the gut and are allochthonous (i.e., formed in another place). Autochthonous strains 
have a long-term association with a particular host, and they form stable populations of a 
characteristic size in a particular region of the gut. It is often difficult to determine whether 
or not a particular microorganism is truly autochthonous to a particular host (Tannock, 
2004). 
3. The role of lactic acid bacteria in the functional food concept 
3.1 The functional food concept 
Functional food is food that promotes human health above the provision of basic nutrition. 
The term “functional food” was first proposed in Japan two decades ago and legally 
approved there as Food for Specified Health Use (FOSHU). A relatively recently proposed 
working definition describes functional food as “food that can be satisfactorily 
demonstrated to affect beneficially one or more target functions in the body, beyond 
adequate nutritional effects, in a way relevant to an improved state of health and well-being 
and/or reduced risk of diseases” (Contor, 2001). Functional foods are also known as 
designer foods, medicinal foods, nutraceuticals, therapeutic foods, super foods, 
foodiceuticals, and medifoods (Shah, 2001). Functional food has a significant and growing 
global market, of which the largest segment in Europe, Japan and Australia comprises food 
containing probiotics, prebiotics and synbiotics (Stanton et al., 2005). 
3.2 Probiotics 
The idea that LAB prevents intestinal disorders and diseases is nearly as old as the science 
of microbiology (Molin, 2001). Therefore, in the development of probiotic food intended for 
human consumption, strains of LAB have most commonly been used. The term “probiotic” 
(Greek: for life) was first used by Lilly and Stillwell (1965). “Probiotic” was later more 
widely used and defined by Parker (1974), and further improved by Fuller (1989) with the 
following definition: “A live microbial food supplement which beneficially affects the host 
animal by improving its intestinal microbial balance”. This definition has later been slightly 
revised (Schaafsma, 1996; Schrezenmeir & de Vrese, 2001) to “Foods containing live and 
defined bacteria, which when given in sufficient numbers, exert beneficial effects by altering 
the microflora in the host” or as expressed by Salminen et al., (1998) “Viable preparation in 
food or dietary supplements to improve the health of humans and animals”. According to 
these definitions, an impressive number of microbial species and genera can be considered 
as probiotics. However, only strains classified as LAB are (due to their traditional use in 
food) currently considered of importance in regard to food and nutrition. 
3.3 Prebiotics 
Since the viability of the live bacteria in food products and during transit through the GIT 
may be variable, the “prebiotic” concept has been developed. A prebiotic is defined as a 
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“non-digestible food ingredient that beneficially affects the host by selectively stimulating 
the growth and/or activity of one or a limited number of bacteria in the colon that can 
improve the host health” (Gibson & Ruberfroid, 1995). Thus, selective growth of certain 
indigenous gut bacteria is improved by the administration of the prebiotic and thereby any 
viability problems of orally administered bacteria in the upper GIT can be overcome. Some 
oligosaccharides, due to their chemical structure, are resistant to digestive enzymes and 
therefore pass into the large intestine where they become available for fermentation by 
saccharolytic bacteria. Compounds that are either partially degraded or not degraded by the 
host and are preferentially utilized by probiotic bacteria as a carbon and/or energy source. 
The criteria which allow classification of a food ingredient as a prebiotic, are defined by 
Fooks and Gibson (2002), and include the following statements, ex. fructo-oligosaccharides, 
xylo-oligosaccharides, lactose derivatives such as lactulose, lactitol, galacto-oligosaccharides 
and soyabean oligosaccharides. 
i. It must be neither hydrolysed, nor absorbed in the upper part of the GIT. 
ii. It should be selectively fermented by one or a limited number of potentially beneficial 
bacteria in the colon. 
iii. Its presence should alter the colonic microbiota towards a healthier composition. 
iv. It should induce effects which are beneficial to the host’s health. 
3.4 Synbiotics 
A further possibility in microflora management procedures is the use of synbiotics, i.e., the 
use in combination of probiotics and prebiotics (Gibson & Roberfroid, 1995). The live 
microbial additions may be used in conjunction with a specific substrate for growth and the 
end result should be improved survival of the probiotic, which has a readily available 
substrate for its fermentation, as well as the individual advantages that each may offer 
(Fooks & Gibson, 2002). Many studies suggest that the consumption of synbiotic products 
has higher beneficial effects on the human health than probiotic or prebiotic products 
(Gmeiner et al., 2000), leading to improved survival of probiotic bacteria during the storage 
of the product and during the passage of the intestinal tract. Moreover, the synbiotic 
product may allow an efficient implantation of probiotic bacteria in colonic microbiota, 
because the prebiotic has a stimulating effect on the growth and/or activities of both the 
exogenous and the endogenous bacteria (Champagene & Gardner, 2005). 
3.5 Important aspects for selection of probiotic strains 
When selecting a probiotic strain, a number of aspects should be considered, and the 
theoretical basis for selection should involve safety, functional as well as technological 
aspects (Salminen et al., 1998; Adams, 1999; Saarela et al., 2000). When selecting a preferable 
probiotic strain, several aspects of functionality have to be considered, as specified below: 
i. Strains for human use are preferably of human origin and isolated from a healthy 
human GIT and non-pathogenic 
ii. must survive through upper GIT and arrive alive at its site of action and able to 
function in the gut environment  
iii. adhere to the intestinal epithelium cell lining and colonize the lumen of the intestinal 
tract 
iv. strains should not carry transmissible antibiotic resistance genes 
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v. must be able to survive GI transit (acid and bile salt tolerant) 
vi. must have good technological properties so that it can be manufactured and 
incorporated into food products without loosing viability and functionality or creating 
unpleasant flavors or textures 
vii. functional aspects include viability and genetic stability  
3.5.1 Acid and bile tolerance  
Probiotic lactobacilli encounter various environmental conditions upon ingestion by the 
host and during transit in the GIT. Firstly, they need to survive the harsh conditions of the 
stomach. Humans secrete approximately 2.5 litres of gastric juice each day, generating a 
fasting pH of 1.5, increasing to pH 3 to 5 during food intake and that the food transit time 
through the human stomach is about 90 minutes. The aggregation of cells could possibly be 
explained by an increased hydrophobicity of the cell surface at low pH. The cell envelope of 
gram-positive bacteria consists of an inner plasma membrane and a thick outer layer of 
peptidoglycan. In contrast to gram-negative bacteria, cell walls of gram-positive bacteria 
contain large amounts of negatively charged teichoic acids (polymers of glycerol or ribitol 
joined by phosphate groups). Hence, one can assume that the teichoic acids become 
protonated at low pH, leading to a more hydrophobic surface. Ingested microorganisms 
must endure numerous environmental extremes to survive in the human GIT. Bile tolerance 
is one of the most essential criteria for the selection of a probiotic strain. Bile acids are 
synthesized in the liver from cholesterol and are secreted from the gall-bladder into the 
duodenum, where they play an important role in the digestion of fat. Bile acids are 
conjugated to either glycine or taurine. Bile is a digestive secretion that plays a major role in 
the emulsification of lipids. Bile acids are surface active, amphipathic molecules with potent 
antimicrobial activity and act as detergents, disrupting biological membranes. It has the 
ability to affect the phospholipids, proteins of cell membranes and disrupt cellular 
homeostasis. Therefore, the ability of pathogens and commensals to tolerate bile is likely to 
be important for their survival and subsequent colonization in the GIT (Begley et al., 2005). 
In our study, we have isolated Lactobacillus rhamnosus Fb from healthy human infant feces, is 
a gram-positive, catalase negative, non-motile and non-spore forming rod-shaped organism 
(De Man et al., 1960). Its ability to ferment ribose, rhamnose and growth at 15°C and 45°C 
indicate that it belongs to the group Streptobacterium (Orla-Jensen, 1943). The identity of the 
L. rhamnosus Fb was confirmed by 16S rDNA sequence analysis. The primary requirement 
for potential probiotic organisms is to survive during the passage through the acidic (pH 1-
3) environment of stomach. L. rhamnosus survives at pH 2 for 2 h, 87% of total cells remain 
viable, a sufficiently long time for the cells to pass through the stomach and reach their site 
of action in the intestine. L. rhamnosus show high survival which is satisfactory especially as 
probiotic strains can be buffered by food or other carrier molecules and in fact are not 
directly exposed to such a low pH in the stomach. After passage through acidic condition 
cells were exposed to bile salt (0.1% pancreatin, 0.5% bile salt, pH 8) viability increase after 3 
h of incubation to 95%. Mimicking gastro-intestinal transit, we observed that the bacterial 
stress originated by low pH may be overcome after the subsequent treatment in presence of 
bile (Charteris et al., 1998). A bile concentration of 0.3% is usually used for screening of bile 
tolerant strains, as this is considered as an average intestinal bile concentration of the human 
GIT (Gilliland et al., 1984). L. rhamnosus possesses the ability to grow in the presence of 0.4% 
phenol and remain viable in 0.6% phenol, a toxic metabolite produced by intestinal bacteria 
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during putrefaction in the GIT (Khedekar, 1988). L. rhamnosus also possesses the ability to 
grow in the presence of 6% NaCl (Jacobsen et al., 1999). The ability of L. rhamnosus cells to 
survive in the presence of bile, NaCl and phenol can help them to survive, grow, colonize 
and elicit the beneficial effects to the host. 
4. Health benefits of functional probiotic culture 
A number of health benefits are claimed in favour of products containing probiotic 
organisms including antimicrobial activity, gastrointestinal infections, improvement in 
lactose metabolism, antimutagenic properties, anticarcinogenic properties, reduction in 
serum cholesterol, anti-diarrhoeal properties, immune system stimulation, improvement in 
inflammatory bowel disease and suppression of Helicobacter pylori infection (Ambalam et al., 
2009; 2011; Kurmann & Rasic, 1991; Shah, 2007). Some of the health benefits are well 
established, while other benefits have shown promising results in animal models. However, 
additional studies are required in humans to substantiate these claims. Health benefits 
imparted by probiotic bacteria are strain specific, and not species- or genus-specific. It is 
important to note that no strain will provide all proposed benefits, not even strains of the 
same species, and not all strains of the same species will be effective against defined health 
conditions. The strains of Lactobacillus and Bifidobacterium are able to restore the normal 
balance of microbial populations in the intestine and most commonly used as probiotics 
(Shah, 2006). 
4.1 Antimicrobial activity of probiotic Lactobacillus rhamnosus  
Many mechanisms have been postulated by which Lactobacilli could produce antimicrobial 
activity. In addition to their competitive inhibition of the epithelial and mucosal adherence 
of pathogens and inhibition of epithelial invasion by pathogens, lactobacilli and 
bifidobacteria show antimicrobial activity by producing antimicrobial substances and/or 
stimulating mucosal immunity (Servin, 2004). Probiotic bacteria produce organic acids, 
hydrogen peroxide and bacteriocins as antimicrobial substances that suppress the 
multiplication of pathogenic and putrefying bacteria. Lactic and acetic acids account for 
over 90% of the organic acids produced. Lowering of pH due to lactic acid or acetic acid 
produced by these bacteria in the gut has a bacteriocidal or bacteriostatic effect. Lactobacillus 
rhamnosus has shown antimicrobial activity against Escherichia coli, Enterobacter aerogenes, 
Salmonella typhi, Shigella sp., Proteus vulgaris, Pseudomonas aeruginosa, Serratia marcescens, 
Staphylococcus aureus, Bacillus subtilis, Bacillus megaterium, Bacillus cereus, Helicobacter pylori, 
Campylobacter jejuni, and Listeria monocytogenes (Ambalam et al., 2009). L. rhamnosus produces 
other antimicrobial metabolites, as evidenced from the antimicrobial activity of Cell Free 
Culture filtrate (CFC) even when Extracellular Protein Concentrate (EPC) (independently) 
was less active. This evidence suggests the multifactorial nature of the antimicrobial activity 
and possibly a synergistic effect. Roles of other metabolites remain to be identified. 
4.2 Classification of bacteriocins from Lactic acid bacteria 
Bacteriocins of LAB are a heterogeneous group of bacterial antagonists and several 
classification criteria have been used to group them. The bacteriocins have been divided into 
three main categories: Class I Lantibiotics ribosomally synthesized peptides that undergo 
extensive post-translational modifications for ex. Nisin. Class II Non-lantibiotic peptides  
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ribosomally synthesized peptides that undergo minimal post-translational modification. 
They have diverse chemical and genetic characteristics. They have been sub-divided into 
three main groups: (a) single peptides, often with a characteristic YGNGVXC amino acid 
motif near the N-terminus (b) two-peptide bacteriocins (c) In Nes’ classification bacteriocins 
produced by the cell’s general secretory (sec) pathway and in Klaenhammer’s classification, 
thiol-activated peptides. Class III Non-lantibiotic, heat labile proteins. These are relatively 
uncommon among the antibacterial compounds of LAB, Class IV A fourth category of 
complex bacteriocins containing protein and lipid or carbobydrate moieties was included in 
Klaenhammer’s classification (Klaenhammer, 1993) but Nes and coworkers (Nes et al., 1996) 
excluded this category because these compounds have not been purified and evidence for 
them is based on loss of activity following treatment with carbohydrate-or lipid-hydrolysing 
enzymes and Class V bacteriocins with circular, unmodified structure ex. enterocin (Eijsink, 
et al., 1998; Guyonnet et al., 2000). L. acidophilus produces various bacteriocins and 
antibacterial substances such as Lactocidin, Acidolin, Acidophilin, Lactacium-B and 
inhibitory protein (Shah, 1999).  
4.3 Characteristics of antimicrobial protein(s) of Lactobacillus rhamnosus 
Antimicrobial activity of Cell Free Culture filtrates (CFC) against the test organisms increase 
with the culture age of L. rhamnosus Fb and became stable when culture reached the 
stationary phase. A similar antimicrobial spectrum of CFC filtrate was observed against all 
the test organisms (Fig. 1, b & d). The antimicrobial spectrum of Extracellular Protein 
Concentrate (EPC) against the test organisms changed with culture age. Antimicrobial 
activity against E. coli was observed in the initial growth phase, activity increases with 
culture age upto 18 h, it decreases later with increasing culture age (Fig. 1, a & c). 
Antimicrobial activity against Ent. aerogenes, B. subtilis, B. megaterium and Staph. aureus 
appeared after 6 h of growth and increased with culture age became stable in stationary 
phase. Whereas activity against Shigella sp., Ps. aeruginosa and B. cereus was observed after 12 
h of growth and increased with culture age upto 30 h before decreasing marginally. 
Antimicrobial activity against S. typhi and P. vulgaris was observed in stationary phase and 
it did not change much with the increase in culture age. The antimicrobial extracellular 
proteins are produced during exponential and stationary phases. Changes in the 
antimicrobial activity spectrum of the EPC during different growth phases provide evidence 
that the EPC is a mixture of antimicrobial peptides and its composition changes with the 
culture age (Ambalam et al., 2009). Antimicrobial activity spectrum changes with culture 
age, indicates that the antimicrobial activity is attributed to the mixture of antimicrobial 
peptides. Antimicrobial activity of EPC shows activity over broad pH range (2-9) but the 
activity varies with test organisms. At pH 2 to 5 and 8 mode of inhibition was bactericidal 
against E. coli, Ent. aerogenes, S. typhi, Shigella sp., P. vulgaris, Ser. marcescens, Ps. aeruginosa, 
Staph. aureus, B. megaterium, B. cereus and B. subtilis. While at pH 6, 7 and 9 the activity was 
bacteriostatic. Antimicrobial activity of EPC was thermostable (60 min at 100°C), 
thermostability was evidenced from the bactericidal activity of heat treated EPC, heat 
treatment caused complete loss of activity against Ps. aeruginosa and Bacillus spp. Heat 
stability of antimicrobial proteins has been suggested to be the major feature of low 
molecular weight bacteriocins and arises from complex pattern of disulphide intramolecular 
bonds that stabilize secondary structures by reducing the number of possible unfolded 
structures (Cintas et al., 1995). Currently we do not know the reasons for the stability of  
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Fig. 1. Association of antimicrobial spectrum of EPC produced by L. rhamnosus Fb culture 
during logarithmic and idiophasic growth. (a) & (c) Antimicrobial activity of Extracellular 
Protein Concentrate (EPC) and (b & d) Cell Free Culture Filtrate (CFC) of Lactobacillus 
rhamnosus produced at the different growth phases (6, 12, 18, 24, 30 and 36 h) determined by 
well-diffusion assay against E. coli, Ent. aerogenes, S. typhi, Shigella sp., P. vulgaris, Ps. aeruginosa, 
B. subtilis, B. megaterium, B. cereus and Staph. aureus 
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antimicrobial peptides but the work is in progress to further characterize the structure and 
functions of EPC. Sensitivity of EPC to proteolytic enzymes like Proteinase K, Trypsin and 
Pepsin shows strain specificity, it varies with test organism which also further indicates the 
proteinaceous nature of the active agent. EPC treated with Proteinase K cause reduction in 
antimicrobial activity against B. megaterium (80%), Staph. aureus (79%), B. cereus (71%), P. 
vulgaris (60%), Ser. marcescens (53%), S. typhi (46%), E. coli (41%), Ent. aerogenes, Shigella sp. 
and Ps. aeruginosa marginally (<10%). Proteinase K exhibits broad substrate specificity. 
Proteinase K degrades many proteins in the native state even in the presence of detergent. 
The predominant site of cleavage is the peptide bond adjacent to the carboxyl group of 
aliphatic and aromatic amino acids which block alpha amino group. It is commonly used for 
its broad specificity (Ebeling et al., 1974). Trypsin cleaves peptide chains mainly at the 
carboxyl site of the amino acids lysine or arginine, except when either is followed by 
proline. Antimicrobial activity of EPC treated with trypsin was completely lost against Ps. 
aeruginosa, Staph. aureus and Bacillus spp. indicates the presence of the active site for 
antimicrobial action may be present at the carboxyl site of protein. Pepsin is most efficient in 
cleaving peptide bonds between hydrophobic and preferably aromatic amino acids such as 
phenylalanine, tryptophan, and tyrosine (Dunn, 2001). EPC treated with pepsin results in 
complete loss of antimicrobial activity against S. typhi and Staph. aureus while partially 
reduced against Bacillus spp. Variable sensitivity of antimicrobial activity of EPC against test 
organisms imply the presence of a more than one antimicrobial peptides active against 
different test organisms. Gel permeation chromatography (Sephadex G-25) of EPC provides 
additional evidence of inhibitory protein is low molecular protein. Gel electrophoresis 
(Tricine SDS PAGE) of EPC shows that proteins present in EPC resolved into three bands, 
one diffuse band representing low molecular weight peptides (4 kDa) and the other marking 
the presence of higher molecular weight proteins (Schagger & Von Jagow, 1987). Gel over-
layer confirmed that inhibition of the test organisms was due to the diffuse band of low 
molecular weight protein(s). EPC is a dynamic mixture of antimicrobial peptides, since the 
antimicrobial spectrum of the EPC is intimately associated with the growth phase. The 
following experimental evidences related to heat stability, sensitivity to proteolytic 
enzymes, and gel permeation chromatography further implicate the presence and 
involvement of more than one antimicrobial peptides in the EPC. Purification and 
characterization of antimicrobial peptides of Lactobacillus rhamnosus Fb strain provides novel 
approach as anti-infective drug, as it shows wide spectrum of antimicrobial action against 
human pathogens and food spoilage organisms. It has also potential for food additives, 
treatment of antibiotic resistant organisms. Probiotic formulation derived from this culture 
can be used to treat gastrointestinal problems including various forms of dysbacteriosis. 
However further studies are necessary to investigate the possibility of using this novel 
antimicrobial peptides as an anti-infective agent and in vivo study. 
4.4 Present approaches and future prospects for bacteriocins in food application 
The increasing demand for high-quality ‘safe’ foods that are not extensively processed has 
created a niche for natural food preservatives. The ideal natural food preservative should 
fulfil the following criteria (Hill et al., 2002), acceptably low toxicity, stability to processing 
and storage, efficacy at low concentration, economic viability, no medical use, and no 
deleterious effect on the food. While most bacteriocins fulfil all these criteria, to date nisin is 
the only bacteriocin to be commercially exploited on a large scale, having gained Food and 
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Drug Administration (FDA) approval in the USA in 1988, although it had been in use in 
Europe for some time (the WHO approved the use of nisin in 1969). Its success has 
stimulated further research targeted towards identifying new bacteriocins from LAB which 
potentially could be used in a similar manner. Many bacteriocins have now been 
characterized that exhibit antibacterial activity against a range of pathogenic and food 
spoilage bacteria. It is to be expected that bacteriocins and bacteriocin-producing LAB (used 
as starters or protective cultures) will find many roles in both fermented and nonfermented 
foods as a means of improving food quality, naturalness and safety. Three approaches are 
commonly used in the application of bacteriocins for biopreservation of foods (Schillinger et 
al., 1996). Inoculation of food with LAB that produce bacteriocin in the products. The ability 
of the LAB to grow and produce bacteriocin in the products is crucial for its successful use, 
Addition of purified or partially-purified bacteriocins as food preservatives, use of a 
product previously fermented with a bacteriocin producing strain as an ingredient in food 
processing. 
4.5 Antimutagenic properties 
Humans are continually exposed to a variety of natural and artificial mutagens generated by 
industrial and environmental activities (Vorobjeva et al., 2002). One of the possible ways of 
the lowering of mutation pressure on animals and human is the increasing antimutagens 
levels and of the antimutagenic activity of bacteria, predominantly those inhabiting the 
intestine of mammals being the ingredients of probiotic, used in food processing and 
ensilage. Probiotic organisms are reported to bind mutagens to the cell surface (Orrhage et 
al., 1994). Probiotic L. rhamnosus 231 cells has ability to bind, biotransform and detoxify 
different mutagens like acridine orange (AO), N-methyl-N’-nitro-N-nitrosoguanidine 
(MNNG), 2-amino-3,8-dimethylimidazo-[4,5-f]-quinoxaline (MeIQx) (Ambalam et al., 2011). 
Binding of AO by Lr 231 is due to adsorption, thereby leading to removal of mutagen in 
solution and is instantaneous, pH- and concentration-dependent. Whereas, binding of 
MNNG and MeIQx by Lr 231 results into biotransformation leading to detoxification with 
subsequent loss of mutagenicity as determined by spectral analysis, thin layer 
chromatography and Ames test. Lr 231 exhibits ability to bind and detoxify potent 
mutagens, and this property can be useful in formulating fermented foods for removal of 
potent mutagens. Similar results were also observed by Sreekumar & Hosono (1998) 
instantaneous binding of the mutagen Trp-P-1 by Lactobacillus gasseri. Lankaputhra and 
Shah (1998) studied the antimutagenic activity of organic acids produced by probiotic 
bacteria against several mutagens and promutagens. In their study, butyric acid showed a 
broad-spectrum antimutagenic activity against all mutagens or promutagens studied and 
live bacterial cells showed higher antimutagenicity than killed cells. Probiotic bacteria are 
reported to reduce faecal enzymatic activities including ┚-glucuronidase, azoreductase, and 
nitroreductase, which are involved in activation of mutagens (Goldin & Gorbach, 1984). 
4.6 Anticarcinogenic properties 
Bacteria and metabolic products such as genotoxic compounds (nitrosamine, heterocyclic 
amines, phenolic compounds, and ammonia) are responsible for colorectal cancer. The 
consumption of cooked red meat, especially barbequed meat, and low consumption of fibre 
are reported to play a major role in causing colorectal cancer. The colonic flora is also 
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reported to cause carcinogenesis mediated by microbial enzymes such as ┚-glucuronidase, 
azoreductase, and nitroreductase, which convert procarcinogens into carcinogens. Certain 
strains of L. acidophilus and Bifidobacterium spp. are reported to decrease the levels of 
enzymes such as ┚-glucuronidase, azoreductase, and nitroreductase responsible for 
activation of procarcinogens and consequently decrease the risk of tumour development 
(Yoon et al., 2000). Short chain fatty acids produced by L. acidophilus and Bifidobacterium, L. 
plantarum and L. rhamnosus are reported to inhibit the generation of carcinogenic products 
by reducing enzyme activities (Cenci et al., 2002). The anticarcinogenic effect of probiotic 
bacteria reported is due to the result of removal of sources of procarcinogens (or the 
enzymes that lead to their formation) improvement in the balance of intestinal microflora, 
normalized intestinal permeability (leading to prevention or delaying of toxin absorption), 
strengthening of intestinal barrier mechanisms, and activation of non-specific cellular factors 
(such as macrophages and natural killer cells) via regulation of ┛-interferon production. 
Orally administered Bifidobacterium is also reported to play a role in increasing production of 
IgA antibodies and functions of Peyer’s patch cells (Singh et al., 1997).  
4.7 Reduction in serum cholesterol 
The level of serum cholesterol is a major factor for coronary heart disease, and elevated 
levels of serum cholesterol, particularly LDL-cholesterol, have been linked to an increased 
risk (Liong & Shah, 2006). There is a high correlation between dietary saturated fat or 
cholesterol intake and serum cholesterol level. Feeding of fermented milk containing very 
large numbers of probiotic bacteria to hypercholesterolaemic human subjects has resulted in 
lowering cholesterol from 3.0 to 1.5 g/L. Probiotic bacteria are reported to de-conjugate bile 
salts: deconjugated bile acid does not absorb lipid as readily as its conjugated counterpart, 
leading to a reduction in cholesterol level. L. acidophilus is also reported to take up 
cholesterol during growth and this makes it unavailable for absorption into the blood 
stream (Klaver & Meer, 1993). 
5. Conclusions 
Lactobacillus strains play an important role in food fermentation processes. Modern concepts 
or perspectives of the application of Lactobacillus strains include the following selections; the 
best adapted and safe for human application as it is an important biodefense factor in 
human intestinal tract, non-pathogenic, with probiotic effects and/or health-promoting 
effects and food protective activities. From our study we conclude that L. rhamnosus is a 
potential candidate for probiotic product preparation or as food additives as evidenced by 
its ability to acid-bile tolerance, salt, antimicrobial activity against human pathogens and 
food spoilage organisms. The antimicrobial extracellular low molecular weight proteins are 
produced during exponential and stationary phases. Changes in the antimicrobial activity 
spectrum of the EPC during different phases of growth provide evidence that the EPC is a 
mixture of antimicrobial peptides and its composition changes with the culture age. Strain-
specific thermostability and sensitivity to proteolytic enzymes of antimicrobial peptides 
provide further evidence that the antimicrobial activity of EPC is due to mixture of peptides 
that are heat sensitive and/or resistant. Thermostability of antimicrobial peptides confers 
additional advantage which can survive the thermal processing cycle of foods and can also 
work over a broad pH range and could therefore be used in acidic food condition. These 
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broad antimicrobial spectra produced by L. rhamnosus are potentially valuable in topical 
treatment, bio-control, food additives, and other applications that aim at eradicating gram-
positive and gram-negative pathogens or non-pathogenic contaminants in the targeted 
environment. Further work on the purification, characterization of these antimicrobial 
peptides and mode of action is in progress.  
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